A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. The researchers behind the study have now started a clinical trial on patients.
source https://www.sciencedaily.com/releases/2025/05/250508112321.htm
Rise of AI means companies could pass on SaaS
-
The writing is on the wall as AI companies race to add vertical
functionality
Software stocks have taken a beating over the last month as investors grow
...
8 hours ago
No comments:
Post a Comment